Nikolaos Bournakas

ORCID: 0009-0006-7810-432X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacteriophages and microbial interactions
  • Antimicrobial Peptides and Activities
  • Chemical Synthesis and Analysis
  • RNA Interference and Gene Delivery
  • Cancer therapeutics and mechanisms
  • Synthesis and biological activity
  • Click Chemistry and Applications

Bicycle Therapeutics (United Kingdom)
2022-2024

Abstract Penicillin binding proteins (PBPs) are well validated antimicrobial targets, but the prevalence of β-lactamase driven resistance and, more rarely, target-based mutations, necessitates new classes PBP-targeting drugs. Here we describe discovery and optimisation novel, bicyclic peptide (Bicycle ® ) inhibitors E. coli PBP3 ( Ec PBP3) using a proprietary phage display platform, their conjugation to linear peptides confer outer membrane permeation. These molecules exhibited high-affinity...

10.1101/2024.03.20.581580 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-03-21

Growing antibiotic resistance is rapidly threatening the efficacy of treatments for Gram-negative infections. Bicycle molecules, constrained bicyclic peptides from diverse libraries generated by bacteriophage display that bind with high affinity to a chosen target are potential new class antibiotics. The generally impermeable bacterial outer membrane currently limits access bacteria. conjugation active offers an avenue penetration. Here, we investigate which physicochemical properties...

10.1021/acsinfecdis.3c00427 article EN cc-by ACS Infectious Diseases 2024-06-12
Coming Soon ...